Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects more than 24 million people worldwide and represents an immense medical, social and economic burden. While a vast array of active pharmaceutical ingredients (API) is available for the prevention and possibly treatment...

Full description

Bibliographic Details
Main Authors: Eniko Manek, Ferenc Darvas, Georg A. Petroianu
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Molecules
Subjects:
Alzheimer’s disease
polymer nanoparticle
biodegradable
chitosan
blood-brain barrier
CNS delivery
Online Access:https://www.mdpi.com/1420-3049/25/20/4866

Similar Items

Similar Items